Preliminary Results for the year ended 31 December 2025
26 March 2026
Preliminary Results of the year ended 31 December 2025
26 March 2026
Whitepaper – How to avoid preclinical risk by getting lentiviral decisions right in discovery
Response to Rule 2.8 Announcement
On-the-Fly Optimization of Anion-Exchange Chromatography for High-Purity AAV Separation
Extension of PUSU deadline
Enhanced Transcriptional Insulation of Lentiviral Vectors using “Sequence-upgraded PolyA Long Terminal Repeats” or “supA-LTRs”
2.4 Announcement dated 14 January 2026
14th January 2026
Webinar: Optimising Viral Vector Manufacturing with CDMO Expertise and Innovation
18 November 2025
Webinar: Driving Down the Cost- Optimising CGT with the Right CDMO Partner
13 November 2025
Stifel US Healthcare Conference 2025
17 November 2025
Jefferies Global Healthcare Conference 2025
15 December 2025
